On February 24, 2022, the U.S. Food and Drug Administration (FDA) revised the emergency use authorization for tixagevimab co-packaged with cilgavimab (EVUSHELD™) to change the initial dose for the authorized use as pre-exposure prophylaxis of COVID-19 in certain adults and pediatric patients.
North Carolina & Florida Home Health Agencies to See Review Choice Demonstration Changes
The Centers for Medicare & Medicaid Services (CMS) announced that beginning April 1, 2022, home health agencies in Florida (FL) and North Carolina (NC) will be subject to a 25% reduction in payment if they choose not to participate in Medicare’s ongoing Review Choice Demonstration (RCD).
3 Things to Know About Hospital Revenue Cycle Management Labor and Hospital Billing Services in 2022
Healthcare has been experiencing unprecedented labor challenges since the beginning of the COVID-19 pandemic, but this hasn’t been limited to the clinical world.
The administration side has also seen challenges, with leaders opting to invest in remote labor and rethink much of their hospital revenue cycle management staffing strategy. Some have even considered outsourcing to hospital billing services. To keep up, leaders like you will need to stay on top of how these challenges are impacting healthcare organizations and how hospital revenue cycle management solutions can step in to fill the gaps. To help you get started, here’s an overview of what you need to know about hospital revenue cycle management labor challenges today.
CMS to Implement Claim Edit for Hospice Transfers
Effective July 1 2022, a claims processing edit to prevent gap billing between hospice transfers will be implemented. Per Change Request (CR) 12619 Gap Billing Between Hospice Transfers, a patient can change hospices only once per benefit period (60-day or 90-day). When the patient transfers to a different hospice, he or she continues in the same benefit period. To transfer hospice programs, the individual or representative must file, with the hospice from which care has been given and with the newly designated hospice, a statement that includes the following information:
CMS Releases Billing Code For New COVID-19 Omicron Variant Treatment
On February 11, the US Food and Drug Administration (FDA) authorized the emergency use of the monoclonal antibody bebtelovimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients when all of these apply:
